Equine metabolism of buspirone studied by high-performance liquid chromatography/mass spectrometry.

This study examines how the anti-anxiety drug buspirone is metabolized and excreted in horses using advanced analytical techniques.

Study Overview

• The primary purpose of this study was to understand how horses metabolize and excrete buspirone, a non-sedating drug used to treat anxiety.
• The researchers administered a 100 mg dose of buspirone to the horses and then collected urine samples at different intervals, from 1 to 12 hours post-administration.
• The urine samples were analyzed using high-performance liquid chromatography/electrospray ionization mass spectrometry (HPLC/ESI-MS) in the positive ion mode. This is a sophisticated analytical technique that allows for the separation, identification, and quantification of different chemical compounds.

Findings

• The analysis revealed that the buspirone was not only excreted as-is (or unchanged) but also metabolized into three main classes of metabolites: monohydroxy, dihydroxy, and dihydroxymethoxy products.
• The presence of these metabolites suggests that the buspirone underwent various transformations in the horse’s body, including oxidation and methoxylation processes.
• Notably, all urine samples collected over the 12-hour period post-administration demonstrated detectable levels of both the unchanged buspirone and its metabolites. This indicates that the metabolism and elimination of buspirone in horses is fairly consistent within this timeframe.

Implications

• Understanding how a drug is metabolized and excreted is crucial for determining its dosage, efficacy, and potential side effects. These findings provide valuable insights into how buspirone operates within the equine body, which could guide veterinarians and horse owners in its application for equine anxiety management.
• Additionally, the use of HPLC/ESI-MS to investigate buspirone metabolism showcases the method’s utility in veterinary pharmacology studies. It could therefore be employed in future research to analyze other drugs used in equine medicine.